Rendapid en es it fr

Rendapid Brand names, Rendapid Analogs

Rendapid Brand Names Mixture

  • No information avaliable

Rendapid Chemical_Formula


Rendapid RX_link

Rendapid fda sheet

Rendapid FDA

Rendapid msds (material safety sheet)

Rendapid Synthesis Reference

W. F. Hoffman et al., U.S. Pat. 4,444,784 (1984)

Rendapid Molecular Weight

418.566 g/mol

Rendapid Melting Point


Rendapid H2O Solubility

0.76 mg/L

Rendapid State


Rendapid LogP


Rendapid Dosage Forms

Tablet (oral)

Rendapid Indication

For the treatment of hypercholesterolemia.

Rendapid Pharmacology

Simvastatin, the methylated form of lovastatin, is an oral antilipemic agent which inhibits HMG-CoA reductase. simvastatin is used in the treatment of primary hypercholesterolemia and is effective in reducing total and LDL-cholesterol as well as plasma triglycerides and apolipoprotein B.

Rendapid Absorption

Absorption of simvastatin, estimated relative to an intravenous reference dose, in each of two animal species tested, averaged about 85% of an oral dose. In animal studies, after oral dosing, simvastatin achieved substantially higher concentrations in the liver than in non-target tissues.

Rendapid side effects and Toxicity

No information avaliable

Rendapid Patient Information

Patients should be advised about substances they should not take concomitantly with simvastatin and be advised to report promptly unexplained muscle pain, tenderness, or weakness. Patients should also be advised to inform other physicians prescribing a new medication that they are taking ZOCOR.

Rendapid Organisms Affected

Humans and other mammals